These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 6140906)

  • 1. Efficacy of ipecac and activated charcoal/cathartic. Prevention of salicylate absorption in a simulated overdose.
    Curtis RA; Barone J; Giacona N
    Arch Intern Med; 1984 Jan; 144(1):48-52. PubMed ID: 6140906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-volume whole bowel irrigation and salicylate absorption: a comparison with ipecac-charcoal.
    Olsen KM; Ma FH; Ackerman BH; Stull RE
    Pharmacotherapy; 1993; 13(3):229-32. PubMed ID: 8100628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of activated charcoal and magnesium citrate in the prevention of aspirin absorption in humans.
    Easom JM; Caraccio TR; Lovejoy FH
    Clin Pharm; 1982; 1(2):154-6. PubMed ID: 7185512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated charcoal for gastrointestinal decontamination of the poisoned patient.
    Moores K; Spector R
    Iowa Med; 1986 May; 76(5):231-8. PubMed ID: 2872185
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of kaolin-pectin and activated charcoal for inhibition of aspirin absorption.
    Juhl RP
    Am J Hosp Pharm; 1979 Aug; 36(8):1097-8. PubMed ID: 484570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of charcoal cathartic versus ipecac in reducing serum acetaminophen in a simulated overdose.
    McNamara RM; Aaron CK; Gemborys M; Davidheiser S
    Ann Emerg Med; 1989 Sep; 18(9):934-8. PubMed ID: 2569851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible adsorption (desorption) of aspirin from activated charcoal.
    Filippone GA; Fish SS; Lacouture PG; Scavone JM; Lovejoy FH
    Arch Intern Med; 1987 Aug; 147(8):1390-2. PubMed ID: 3632148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the effects of multiple-dose activated charcoal on the absorption of orally administered salicylate in a simulated toxic ingestion model.
    Barone JA; Raia JJ; Huang YC
    Ann Emerg Med; 1988 Jan; 17(1):34-7. PubMed ID: 3337412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of sorbitol combined with activated charcoal in prevention of salicylate absorption.
    Keller RE; Schwab RA; Krenzelok EP
    Ann Emerg Med; 1990 Jun; 19(6):654-6. PubMed ID: 2188536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of drug absorption in simulated theophylline overdose.
    Minton NA; Glucksman E; Henry JA
    Hum Exp Toxicol; 1995 Feb; 14(2):170-4. PubMed ID: 7779441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated oral administration of activated charcoal for treating aspirin overdose in young children.
    Vertrees JE; McWilliams BC; Kelly HW
    Pediatrics; 1990 Apr; 85(4):594-8. PubMed ID: 2314974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saline catharsis: effect on aspirin bioavailability in combination with activated charcoal.
    Sketris IS; Mowry JB; Czajka PA; Anderson WH; Stafford DT
    J Clin Pharmacol; 1982 Jan; 22(1):59-64. PubMed ID: 7061727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a charcoal-sorbitol mixture as an antidote for oral aspirin overdose.
    Mayersohn M; Perrier D; Picchioni AL
    Clin Toxicol; 1977 Dec; 11(5):561-7. PubMed ID: 608318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated charcoal and syrup of ipecac in prevention of cimetidine and pindolol absorption in man after administration of metoclopramide as an antiemetic agent.
    Neuvonen PJ; Olkkola KT
    J Toxicol Clin Toxicol; 1984; 22(2):103-14. PubMed ID: 6150121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical trial using syrup of ipecac and activated charcoal concurrently.
    Freedman GE; Pasternak S; Krenzelok EP
    Ann Emerg Med; 1987 Feb; 16(2):164-6. PubMed ID: 2879488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Successful therapy of salicylate poisoning using glycine and activated charcoal].
    Mühlebach S; Steger P; Conen D; Wyss PA
    Schweiz Med Wochenschr; 1996 Dec; 126(49):2127-9. PubMed ID: 8999500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal decontamination in the management of the poisoned patient.
    Cupit GC; Temple AR
    Emerg Med Clin North Am; 1984 Feb; 2(1):15-28. PubMed ID: 6151498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of ipecac-induced emesis, orogastric lavage, and activated charcoal for acute drug overdose.
    Tenenbein M; Cohen S; Sitar DS
    Ann Emerg Med; 1987 Aug; 16(8):838-41. PubMed ID: 2887134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does multiple-dose charcoal therapy enhance salicylate excretion?
    Kirshenbaum LA; Mathews SC; Sitar DS; Tenenbein M
    Arch Intern Med; 1990 Jun; 150(6):1281-3. PubMed ID: 2191636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental study of the treatment of salicylate poisoning by activated charcoal].
    Collombel C; Perrot L
    Eur J Toxicol; 1970; 3(6):352-4. PubMed ID: 5520489
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.